FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
We are very excited to launch our new website! Please take a few moments to click around and explore...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...